Bioventus (BVS) Common Equity (2019 - 2026)
Bioventus (BVS) recorded Common Equity of $291.87 million in Q3 2026, up 40.8% from $207.26 million a year earlier and up 5.2% from the prior quarter.
Powered by 
Analysis
Bioventus (BVS) Common Equity (2019 - 2026) Analysis & Trends
At the end of FY2025, Bioventus reported Common Equity of $228.45 million, up 23.1% from FY2024.
- Annual Common Equity has a five-year compound annual growth rate of 9.6% (FY2020 to FY2025).
- Across earlier years, Common Equity came in at $185.6 million in FY2024 (-16.1%), $221.12 million in FY2023 (-46.4%), $412.22 million in FY2022 (-32.2%) and $607.66 million in FY2021 (+321.5%).
- The Q3 2026 figure is the highest quarterly Common Equity since Q4 2022.
- On a year-over-year basis, Common Equity has increased for six consecutive quarters, with growth averaging 14.3% over the last eight quarters.
- Peak year-over-year performance for Common Equity in the last five years was growth of 321.5% in Q4 2021, against a decline of 60.6% in Q2 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $277.41 million (Q2 2026), $234.27 million (Q1 2026) and $228.45 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 266.22 Bn | 242.86 Bn | 5.13 Bn | 54.77 Bn |
| 2 | Abbott Laboratories | 191.31 Bn | 165.77 Bn | 7.39 Bn | 51.62 Bn |
| 3 | Danaher | 166.16 Bn | 145.82 Bn | 3.84 Bn | 53.63 Bn |
| 4 | Intuitive Surgical | 155.98 Bn | 136.40 Bn | 2.08 Bn | 16.12 Bn |
| 5 | Medtronic | 130.05 Bn | 96.18 Bn | 6.34 Bn | 50.85 Bn |
| 6 | Stryker | 123.40 Bn | 109.59 Bn | 4.25 Bn | 23.46 Bn |
| 7 | Boston Scientific | 64.81 Bn | 60.48 Bn | 3.43 Bn | 25.87 Bn |
| 8 | Edwards Lifesciences | 59.87 Bn | 43.18 Bn | 1.35 Bn | 10.96 Bn |
| 9 | Medline | 53.84 Bn | 50.96 Bn | 1.93 Bn | 19.39 Bn |
| 10 | Bioventus | 942.04 Mn | 846.16 Mn | 97.13 Mn | 291.87 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 26, 2026 | 291.87 Mn |
| Jun 27, 2026 | 277.41 Mn |
| Mar 28, 2026 | 234.27 Mn |
| Dec 31, 2025 | 228.45 Mn |
| Sep 27, 2025 | 207.26 Mn |
| Jun 28, 2025 | 201.30 Mn |
| Mar 29, 2025 | 185.48 Mn |
| Dec 31, 2024 | 185.60 Mn |
| Sep 28, 2024 | 186.83 Mn |
| Jun 29, 2024 | 189.06 Mn |
| Mar 30, 2024 | 217.43 Mn |
| Dec 31, 2023 | 221.12 Mn |
| Sep 30, 2023 | 226.46 Mn |
| Jul 1, 2023 | 233.34 Mn |
| Apr 1, 2023 | 240.36 Mn |
| Dec 31, 2022 | 412.22 Mn |
| Oct 1, 2022 | 451.04 Mn |
| Jul 2, 2022 | 592.08 Mn |
| Apr 2, 2022 | 593.81 Mn |
| Dec 31, 2021 | 607.66 Mn |
API Access
Bioventus Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=BVS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "BVS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=BVS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();